HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythrocyte sorbitol dehydrogenase activity in diabetic patients.

Abstract
An increased polyol-pathway activity is implicated in the pathogenesis of some diabetic complications. Little is known about the sorbitol-dehydrogenase (SDH) activity in diabetic patients, although cataract is described in diabetes as well as in SDH deficiency. Therefore, we studied SDH activity and the relation with complications and with sorbitol accumulation in erythrocytes from 96 type 1 diabetics and 29 age- and sex-matched healthy subjects. When comparing these groups erythrocyte sorbitol (ERY-SOR) was significantly (P < 0.001) increased in the diabetic patients, but no difference in SDH could be demonstrated. In the diabetic patients ERY-SOR was predominantly related to the glycaemia (r = 0.37; P < 0.001). The SDH activity correlated with HbA1 (r = 0.20; P < 0.03). In diabetic patients with severe nephropathy the ERY-SOR value is no longer different from the control value. It was concluded that, in poor metabolic control the SDH activity is increased, which counteracts but does not prevent the sorbitol accumulation nor the genesis of complications. In patients with macroalbuminuria the ERY-SOR decreases to the normal range. Since SDH activity is similar in type 1 diabetics and controls the decreased ERY-SOR in this complication might be due to other metabolic pathways.
AuthorsI H De Leeuw, J J Vertommen, E G Rillaerts
JournalDiabetes research and clinical practice (Diabetes Res Clin Pract) Vol. 20 Issue 1 Pg. 51-4 (Apr 1993) ISSN: 0168-8227 [Print] Ireland
PMID8344129 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Blood Glucose
  • Glycated Hemoglobin A
  • L-Iditol 2-Dehydrogenase
Topics
  • Adult
  • Blood Glucose (analysis)
  • Diabetes Mellitus, Type 1 (blood, enzymology)
  • Erythrocytes (enzymology)
  • Female
  • Glycated Hemoglobin (analysis)
  • Humans
  • L-Iditol 2-Dehydrogenase (blood)
  • Male
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: